Not Every Process Should Scale: When Agencies Keep Healthcare Outreach Narrow on Purpose
Not Every Process Should Scale: When Agencies Keep Healthcare Outreach Narrow on Purpose Key Takeaways Why Scaling Outreach in Healthcare M&A Often Reduces Deal Quality The Hidden Cost of Expanding Outreach Beyond Ideal Buyers In healthcare transactions, more outreach does not always equal better results. When outreach is expanded too broadly, sellers attract low-quality buyers […]
Read MoreDesigning Exit Optionality Before You Ever Sell a Majority Stake
Designing Exit Optionality Before You Ever Sell a Majority Stake Key Takeaways Understanding Exit Optionality and Why It Matters Why Exit Optionality Matters Long Before a Majority Sale Many healthcare founders believe exit planning begins when they are “ready to sell.” In reality, the most successful exits are engineered long before a buyer is ever […]
Read MoreSecond Liquidity Events: Planning Beyond the First Exit
Second Liquidity Events: Planning Beyond the First Exit Key Takeaways Understanding Second Liquidity Events For many healthcare practice owners, the first exit—whether a sale to a strategic buyer, private equity, or via an IPO—is a milestone. However, a first exit may not fully realize a practice’s long-term value, and founders often retain equity or operational […]
Read MoreFull Exit, Partial Exit, or Strategic Partnership: CEO Decision Framework
Full Exit, Partial Exit, or Strategic Partnership: CEO Decision Framework Key Takeaways Understanding CEO Exit Options: Full, Partial, and Strategic Partnerships Deciding how to exit your healthcare business is one of the most important choices a CEO can make. Whether you’re running a medical practice, dental group, or a medspa, the options generally fall into […]
Read More
